Farmalider: a trusted B2B partner in the Pharmaceutical Industry.
From generics to biotechnological innovation
With more than 40 years of experience, Farmalider is a pharma-biotech company committed to innovation and driven by a forward-looking vision.
We specialize in the development of fully integrated B2B medicines, acting as a strategic partner of reference in pharmaceutical innovation. Our comprehensive service covers the entire value chain: from ideation and development to intellectual property management, licensing, manufacturing, and final supply.
We are a global leader in pain management, with a broad portfolio of innovative formulations that includes prescription drugs, OTC products, and self-care solutions.
Aligned with our commitment to sustainability, we created the first B2B licensing and supply line designed with a focus on efficiency and environmental responsibility: Farmalider ECO line, a market leader.
Looking ahead, we continue to expand our presence in the field of cutting-edge biotechnological therapies, reinforcing our commitment to advancing health through technology and pharmaceutical innovation.
All our products are developed through manufacturing processes carried out entirely in Spain, at our GMP-certified facilities in Madrid and Valencia.
Our dedication to continuous improvement, solid expertise, and adaptability allows us to make a difference every day, building long-lasting and sustainable relationships with our clients.
At Farmalíder, innovation is at the heart of everything we do. Because by inspiring every day, together we drive a better future.
Our Mission
At Farmalider, our mission is to enlighten healthcare through innovation and sustainability in the global pharmaceuticals landscape, bringing hope to patients and their families with new, promising treatments. Our wide portfolio, featuring over 335 patents and our pioneering ECO product range, makes us the right partner if you want to add unique and value-added products to your portfolio. All our products are developed through our pharmaceutical manufacturing processes entirely in Spain, at our GMP-certified plants in Madrid and Valencia.
We offer fully integrated B2B pharma services that cover the entire pharmaceutical value chain, from drug discovery and intellectual property to licensing, manufacturing, and final supply. Our in-house capabilities ensure high quality, efficiency, and speed-to-market in the competitive pharma industry.
To develop and license Paracetamol 1g tablets in the European market
Presence in 80+ countries in 2025
Global Patent Registrations
European Marketing Authorizations (MAs)
R&D projects on-going
e-CTD updated dossiers
With a strong focus on pain management, our portfolio spans innovative formulations, prescription and OTC medicines, and consumer healthcare products, positioning us among the top pharmaceutical companies in our specialized areas.
We cover the whole B2B value chain, from ideation to commercialization
At Farmalider, we cover the entire value chain, offering fully integrated B2B pharmaceutical services. We specialize in IP and patents, Research and Development (R&D+i), licensing, manufacturing, and supply of FDF pharmaceutical products to other pharmaceutical companies worldwide. All our products are developed and manufactured in-house, covering from the initial research to final supply.
Intellectual Property and Patents
Research and Development (R&D)
Licensing and Regulatory Affairs
Manufacturing and Supply of FDF
Enlightening relationships with our B2B business models
Intellectual property and patents
At Farmalider, innovation is the core of our mission. We don’t just develop pharmaceutical solutions — we envision, create, and protect them through a comprehensive intellectual property strategy. This ensures exclusivity and provides a competitive edge for our B2B partners. We transform ideas into patented solutions
R&D and co-development agreements
We partner with companies to jointly develop new drugs and accelerate market entry. In some cases, we collaborate with other companies, working as partners to co-develop products
License and supply agreements
We develop, license, manufacture, and supply the product, managing the entire value chain to deliver a finished product ready for and with your brand.
Licensing & royalty agreements
We develop, license the product and, through a CMO agreement, you manufacture it.
CMO & CDMO Services
We also offer CMO & CDMO services directly through our own state-of-the-art manufacturing plants, fully equipped to produce nearly all pharmaceutical forms.
Farmalider’s milestones
Lighting up 40 years of history in the pharmaceutical industry
1986
Creation of Farmalider as a pharmaceutical company
2001
Patented ibuprofen oral suspension 4% bottle in Europe
2005
First paracetamol 1g tablets license in Europe
2006
Ibuprofen 600 mg tablets: smallest ibuprofen tablet on the market
2011
Acquisition of our manufacturing plant in Madrid
2012
Worldwide patent for ibuprofen injection solution; paracetamol orodispersible sticks development
2013
Creation of Nutra Essential OTC Company
2014
Development of ibuprofen powder stick
2015
Development of ibuprofen oral suspension sticks
2018
Worldwide patent for sildenafil oral suspension spray
2020
Patented ibuprofen phenylephrine oral suspension; diclofenac spray license
2022
Acquisition of our manufacturing plant in Valencia; paracetamol solution sticks license
2024
Merger of Tollpharma, Edefarm, NutraEssential into one company and rebranding of Farmalider
2025
Launch of Ideeea Therapeutics, Farmalider’s first biotech venture
1986
Creación de Farmalider como compañía farmacéutica
2001
Patente europea de la suspensión oral de ibuprofeno 4% en frasco
2005
Primera licencia europea de comprimidos de paracetamol 1 g
2006
Comprimidos de ibuprofeno 600 mg: el ibuprofeno más pequeño del mercado
2011
Adquisición de nuestra planta de fabricación
2012
Patente mundial de la solución inyectable de ibuprofeno; desarrollo de sticks orodispersables de paracetamol
2013
Creación de Nutra Essential OTC Company
2014
Desarrollo del ibuprofeno en stick en polvo
2015
Desarrollo de los sticks de suspensión oral de ibuprofeno
2018
Patente mundial del spray de suspensión oral de sildenafilo
2020
Patente de la suspensión oral de ibuprofeno con fenilefrina; licencia del spray de diclofenaco
2022
Adquisición de nuestra planta de fabricación en Valencia; licencia de los sticks de solución de paracetamol
2024
Fusión de Tollpharma, Edefarm y NutraEssential en una sola compañía y rebranding de Farmalíder
2025
Lanzamiento de Ideeea Therapeutics, la primera empresa biotecnológica del grupo Farmalider
elEconomista Informa Certificate for Excellence in Management
